Welcome!

News Feed Item

Advanced Wound Care: World Market Prospects 2013-2023

NEW YORK, Jan. 3, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Advanced Wound Care: World Market Prospects 2013-2023

http://www.reportlinker.com/p0733754/Advanced-Wound-Care-World-Market-Pr...

Report Details

The demand for advanced wound care products is expected to rise over the next 10 years, driven by an increase in chronic wounds. This can be attributed to an aging population and an increase in lifestyle related disorders such as diabetes and obesity. Visiongain predicts the total advanced wound care market to be worth $16.3bn in 2023.

The move from traditional wound care treatment to advanced wound care started in the mid 80's, with more and more advanced products coming in to the market. Clinicians and patients now prefer advanced wound care products over traditional products, as they are more efficient in wound healing and reduce hospital stays. While moist wound care products currently dominate the market, wound care devices and biologics are witnessing strong growth. More companies, both multinationals and smaller companies are investing in R&D to make their product lines stronger. However, the growth will depend on more clinical evidence becoming available.

Visiongain's report Advanced Wound Care: World Market Prospects 2013-2023 examines the moist wound care, wound care devices and wound care biologics market with respect to the market size and the growth of leading sub segments from 2013-2023. This report also discusses the leading companies operating in this space and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2023, primarily driven by an increase in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices, and increased patient adoption of existing and newly-marketed products. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interviews with experts within the advanced wound care market. There are 115 tables and figures included. Visiongain has determined that the value of the global advanced wound care market will reach $16.3bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 - all highlighting key business opportunities.

Why you should buy Advanced Wound Care: World Market Prospects 2013-2023

• 148 pages of comprehensive analysis• 2 Exclusive Visiongain interviews with experts from-- Derma Sciences- Shire Regenerative Medicine• 115 tables, charts, and graphs• Global advanced wound care market forecast between 2012-2023• 3 advanced wound care submarket forecasts from 2012-2023- Moist Wound Care- Wound Care Devices- Wound Care Biologics• SWOT analysis for each submarket• Several leading companies identified and 6 profiled -- Kinetic Concepts Inc (KCI)- Smith & Nephew (S&N)- Molnlycke Health Care- ConvaTec- Systagenix Wound Management- Coloplast

You can order this report today

Gain an understanding of the overall advanced wound care market and the leading companies operating in this market by ordering Advanced Wound Care: World Market Prospects 2013-2023.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

Table of Contents

1. Executive Summary1.1 Sector Highlights1.2 Aim, Scope and Format of this Report1.3 Chapter Outline1.4 Research and Analysis Method1.5 Glossary of Terms Relating to Advanced Wound Care

2. Introduction

2.1 What is a Wound?

2.2 Wound Classification

2.2.1 Acute Wounds

2.2.2 Chronic Wounds

2.2.2.1 The Increasing Prevalence of Chronic Wounds

2.2.3 Burns

2.3 The Skin

2.4 The Phases of Wound Healing

2.4.1 The Inflammatory Phase

2.4.2 The Proliferation Phase

2.4.3 The Fibroblastic Phase

2.4.4 The Maturation Phase

2.5 Wound Care

2.5.1 Role of Wound Dressing

2.6 The History of Wound Care

2.7 Wound Care Categories

2.7.1 Traditional Wound Care

2.7.1.1 Gauze Dressings

2.7.1.2 Absorptive Dressings

2.7.1.3 Composite Dressings

2.7.1.4 Compression Therapy

2.7.1.5 Contact Layers

2.7.2 Advanced Wound Care (AWC)

2.7.2.1 Moist Wound Care (MWC)

2.7.2.1.1 Hydrocolloid Dressings

2.7.2.1.2 Foam Dressings

2.7.2.1.3 Alginate Dressings

2.7.2.1.4 Hydrogel Dressings

2.7.2.2 Wound Care Devices

2.7.2.2.1 Negative Pressure Wound Therapy (NPWT)

2.7.2.2.2 Ultrasound for wound therapy

2.7.2.3 Wound Care Biologics

2.7.2.3.1 Skin Replacement Therapies

2.7.2.3.2 Collagen Based Therapies

2.7.2.3.3 Cell Based Therapies

2.8 Regulation of Medical Devices

2.8.1 The US Regulation System

2.8.2 The European Approval and Regulation Process

3. Global Advanced Wound Care Market, 2011-20233.1 The Global Medical Devices Market, 20113.2 Global Wound Care Market, 20113.2.1 Global Wound Care Market Trends, 20113.2.2 Advanced Wound Care Market, 20113.3 Global Advanced Wound Care Market Forecast, 2012-20233.3.1 Global Advanced Wound Care Market Trends, 2012-2023

4. The Moist Wound Care Market, 2011-2023

4.1 The Moist Wound Care Market: Overview

4.2 The Moist Wound Care Market, 2011

4.3 Moist Wound Care Market Forecast, 2012-2023

4.4 The Moist Wound Care Market Segments, 2011

4.4.1 The Hydrocolloid Dressings Market

4.4.2 The Foam Dressings Market

4.4.3 The Alginate Dressings Market

4.4.4 The Hydrogel Dressings Market

4.4.5 Other MWC Dressings Market

4.4.5.1 Hydrofiber Technology, ConvaTec

4.4.5.2 Tegaderm Matrix Dressing with PHI Technology, 3M

4.4.5.3 XTRASORB, Derma Sciences

4.4.5.4 Lipido-Colloidal Technology Dressings, URGO MEDICAL

4.4.5.5 Antimicrobial Dressings

4.5 The Moist Wound Care Pipeline, 2011

4.5.1 NanoDOX, Nanotherapeutics

4.5.2 '1' Primary Wound Dressing, Phytoceuticals

4.6 SWOT Analysis of the Moist Wound Care Market, 2012-2023

4.6.1 Strengths

4.6.1.1 Established Segment of the Market

4.6.1.2 Wide Variety of Products

4.6.1.3 More Effective than Traditional Wound Care

4.6.2 Weaknesses

4.6.2.1 Less Effective than Some Devices and Biologics

4.6.2.2 Weak R&D Pipeline

4.6.3 Opportunities

4.6.3.1 Increasing Prevalence of Chronic Wounds

4.6.3.2 Cheap Alternative to Devices and Biologics

4.6.4 Threats

4.6.4.1 Emerging Technologies May be More Effective

4.6.4.2 Lack of R&D Spending will Stifle Innovation

5. Wound Care Devices Market, 2011-20235.1 Wound Care Devices Market: Overview5.2 The Wound Care Devices Market, 20115.3 The Wound Care Devices Forecast, 2012-20235.3.1 Wound Care Devices Market, 2012-20175.3.2 Wound Care Devices Market, 2017-20235.4 The NPWT Market5.4.1 The NPWT Market, 20115.4.2 Leading NPWT Devices: Product Analysis5.4.2.1 V.A.C. Therapy (KCI)5.4.2.2 RENASYS Systems (Smith & Nephew)5.4.3 Other NPWT Systems, 20115.4.4 The NPWT Market Forecast, 2012-20175.4.5 The NPWT Market Forecast, 2017-20235.5 Ultrasound Wound Therapy Market, 20115.6 Other Wound Care Devices, 20115.6.1 Electrical Stimulation5.6.2 Extracorporeal Shock Wave Therapy5.7 The Wound Care Devices Pipeline5.7.1 dermaPACE, Sanuwave Health5.7.2 O-ACE-Sys (Ingenious Technologies Corporation)5.7.3 Red Light Wave Therapy (Lightwave Technologies)5.8 SWOT Analysis of the Wound Care Devices Market, 2012-20235.8.1 Strengths5.8.1.1 More Effective than Other Forms of Wound Care5.8.1.2 Constant Innovation in the Market5.8.2 Weaknesses5.8.2.1 Dominated by Few Large Companies5.8.2.2 NPWT Dominates the Market5.8.3 Opportunities5.8.3.1 Low Cost NPWT Systems will Drive Growth5.8.3.2 Increasing Prevalence of Chronic Wounds5.8.4 Threats5.8.4.1 Controversy Regarding Safety of NPWT5.8.4.2 Ongoing Legal Battles Threaten Innovation

6. Wound Care Biologics Market, 2011-2023

6.1 Wound Care Biologics Market: Overview

6.2 Wound Care Biologics Market, 2011

6.3 The Wound Care Biologics Market Forecast, 2012-2023

6.3.1 Drivers and Restraints, 2012-2023

6.4 The Skin Replacement Market

6.4.1 The Skin Replacement Market, 2011

6.4.2 Leading Products in the Skin Replacement Market, 2011

6.4.2.1 Dermagraft, Shire Regenerative Medicine

6.4.2.2 Apligraf, Organogenesis

6.4.3 New Technologies

6.4.3.1 Spray on Skin to Treat Venous Leg Ulcers

6.4.4 Other Leading Products, 2011

6.4.5 The Skin Replacement Market Forecast, 2011-2017

6.4.6 The Skin Replacement Market Forecast, 2017-2023

6.5 Collagen Based Therapy Market

6.5.1 Collagen Based Therapy Market, 2011

6.5.2 The Collagen Based Therapy Market Forecast, 2011-2017

6.5.3 The Collagen Based Therapy Market Forecast, 2017-2023

6.6 The Cell Therapy Market

6.6.1 The Cell Therapy Market, 2011

6.6.2 The Cell Therapy Market Forecast, 2011-2017

6.6.3 The Cell Therapy Market Forecast, 2017-2023

6.7 The Biologics Pipeline

6.7.1 Stem Cells

6.7.1.1 Stem Cell Skin Gun, McGowan Institute for Regenerative Medicine at the University of Pittsburgh

6.7.1.2 Adult Stem Cells, Cryo-Cell International and the Snyder Wound Research Institute

6.7.1.3 Mesenchymal Stem Cells, Nara University, Japan

6.7.2 Artificial Skin

6.7.2.1 e-Skin, UC Berkeley

6.7.2.2 Genetically Modified Artificial Skin, University of Cincinnati

6.7.2.3 ReCell, Avita Medical

6.7.3 Automated Artificial Skin Production

6.7.3.1 The Tissue Factory, Fraunhofer Institute

6.7.4 Nanotechnology

6.7.4.1 DermaFuse, Missouri S&T and Mo-Sci Corporation

6.7.4.2 Phytochemical Tissue Bonding, Harvard University Institute of Photomedicine

6.7.4.3 Giant Unilamellar Vesicles, University of Bath

6.7.5 Collagen Based Therapy

6.7.5.1 Artificial Collagen Based Wound Care (Cornell University)

6.8 SWOT Analysis of the Wound Care Biologics Market, 2012-2023

6.8.1 Strengths

6.8.1.1 More Effective than Other Forms of Wound Care

6.8.1.2 New Technology with Constant Innovation

6.8.1.3 Strong R&D Pipeline

6.8.2 Weaknesses

6.8.2.1 Small Start-up Companies Dominate the Market

6.8.2.2 Expensive Technology

6.8.2.3 High Barriers to Entry

6.8.3 Opportunities

6.8.3.1 Strong Innovation will Drive Growth

6.8.3.2 Stem Cells Offer Multiple Opportunities

6.8.3.3 Increasing Prevalence of Chronic Wounds

6.8.3.4 Development of Diagnostic Tests

6.8.4 Threats

6.8.4.1 Controversy Regarding the Effectiveness of Some Biologics

6.8.4.2 High Barriers to Entry will Deter Competitors

6.8.4.3 Competition from MWC and Devices

7. Leading National Advanced Wound Care Market, 2011-20237.1 Regional Breakdown of the Global Advanced Wound Care Market, 20117.2 The Global Advanced Wound Care Market: Regional Forecast, 2012-20237.3 The US Market7.4 The European Market7.4.1 Germany and France7.4.2 The UK Market7.4.3 The Spanish Market7.4.4 The Italian Market7.5 The Japanese Market7.6 The Chinese Market7.7 The Indian Market

8. Leading Companies in Advanced Wound Care Market, 2012-2023

8.1 Leading Companies, 2011

8.2 Kinetic Concepts Inc (KCI)

8.2.1 Apax Partners' Led Consortium Acquires KCI for $6.3bn

8.2.2 Success of VAC Therapy

8.2.3 KCI Expands its Operations

8.3 Smith & Nephew (S&N)

8.3.1 Sales and Performance Analysis, 2011

8.3.2 Regional Breakdown, 2011

8.3.3 Smith & Nephew Advanced Wound Care Sales. 2011

8.3.4 Advanced Wound Management Sales by Region, 2011

8.3.5 Smith & Nephew Pipeline

8.3.6 Smith & Nephew Acquires Kalypto Medical

8.4 Molnlycke Health Care

8.4.1 Molnlycke Sales, 2011

8.4.2 Recent Acquisitions

8.4.2.1 Molnlycke Acquires WoundEL from Gerromed GmbH

8.4.2.2 Molnlycke Acquires Burn and Wound Care Business of Brennen Medical

8.5 ConvaTec

8.5.1 Sales and Performance Analysis, 2011

8.5.2 ConvaTec Advanced Wound Care Sales, 2011

8.5.3 Regional Breakdown, 2011

8.5.4 ConvaTec Research & Development

8.6 Systagenix Wound Management

8.6.1 Systagenix Acquires O2 Insights Inc

8.7 Coloplast

8.7.1 Coloplast Sales and Performance Analysis, 2011

8.7.2 Regional Breakdown, 2011

8.7.3 Coloplast Advanced Wound Care Sales, 2010/2011

8.8 Other Companies, 2011

9. Expert Opinion9.1 Interview with Derma Sciences9.1.1 Perspective of Advanced Wound Care Market9.1.2 Unmet needs of the Industry9.1.3 Do FDA Regulations Stifle Innovation?9.1.4 Role of Moist Wound Care in the Future9.1.5 Market for MEDIHONEY in Moist Wound Care9.1.6 Key Products Driving Company Growth9.1.7 Efficacy of Honey in Comparison to Silver9.2 Interview with Shire Regenerative Medicine9.2.1 Perspective of Wound Care Biologics Market9.2.2 Cost and Reimbursement Issues9.2.3 Outlook for Dermagraft

10. Advanced Wound Care Market, 2012-2023

10.1 Advanced Wound Care Market, 2012-2023

10.1.1 Growth will be driven by an Increasing Prevalence of Chronic Wounds

10.1.2 Emerging Markets will Drive Growth

10.2 The Moist Wound Care Market

10.3 The Wound Care Devices Market

10.4 The Wound Care Biologics Market

List of Tables

Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification SystemTable 2.2 The Classification of Burns by Depth: Degree Classification SystemTable 2.3 The Classification of Burns by SeverityTable 2.4 The Advantages and Disadvantages of Moist Wound CareTable 2.5 The Benefits and Risks of Skin GraftingTable 3.1 Medical Device Market: Global Revenue ($bn) and Market Shares (%) by Sector, 2011Table 3.2 Global Wound Care Market: Revenue ($bn) and Market Shares (%) by Sector, 2011Table 3.3 The Advanced Wound Care Market: Revenue ($bn) and Market Shares (%) by Segment, 2011Table 3.4 The Advanced Wound Care Market Forecast ($bn, %), 2011-2023Table 3.5 Drivers and Restraints for the Advanced Wound Care Market, 2012-2023Table 4.1 The Moist Wound Care Market: Revenue ($bn) and Market Share (%) by Segments, 2011Table 4.2 The Moist Wound Care Market Forecast ($bn, %), 2011-2017Table 4.3 The Moist Wound Care Market Forecast ($bn, %), 2017-2023Table 4.4 Leading Products in Hydrocolloid Dressing Market, 2011Table 4.5 Leading Products in the Foam Dressing Market, 2011Table 4.6 Leading Products in the Alginate Dressing Market, 2011Table 4.7 Leading Products in the Hydrogel Dressing Market, 2011Table 4.8 Moist Wound Care Products Pipeline, 2011Table 4.9 SWOT Analysis of the Moist Wound Care Market, 2012-2023Table 5.1 The Wound Care Device Market: Revenue ($bn) and Market Share (%) by Segments, 2011Table 5.2 The Wound Care Devices Market Forecast ($bn, %), 2011-2017Table 5.3 The Wound Care Devices Market Forecast ($bn, %), 2017-2023Table 5.4 The NPWT Market Forecast ($bn, %), 2011-2017Table 5.5 The NPWT Market Forecast ($bn, %), 2017-2023Table 5.6 Drivers and Restraints in the NPWT Market, 2012-2023Table 5.7 Leading Products in the Ultrasound Wound Therapy Market, 2011Table 5.8 Leading Products in the Electrical Stimulation Market, 2011Table 5.9 Wound Care Devices Development Pipeline, 2011Table 5.10 SWOT Analysis of the Wound Care Devices Market, 2012-2023Table 6.1 The Wound Care Biologics Market: Revenue ($bn) and Market Shares (%) by Segments, 2011Table 6.2 The Wound Care Biologics Market Forecast ($bn, %), 2011-2017Table 6.3 The Wound Care Biologics Market Forecast ($bn, %), 2017-2023Table 6.4 Drivers and Restraints in the Biologics Market, 2012-2023Table 6.5 Other Leading Products in the Skin Replacement Market, 2011Table 6.6 The Skin Replacement Market Forecast ($bn, %), 2011-2017Table 6.7 The Skin Replacement Market Forecast ($bn, %), 2017-2023Table 6.8 Leading Products in the Collagen Based Therapy Market, 2011Table 6.9 The Collagen Based Therapy Market Forecast ($bn, %), 2011-2017Table 6.10 The Collagen Based Therapy Market Forecast ($bn, %), 2017-2023Table 6.11 Leading Products in the Cell Therapy Market, 2011Table 6.12 The Cell Therapy Market Forecast ($bn, %), 2011-2017Table 6.13 The Cell Therapy Market Forecast ($bn, %), 2017-2023Table 6.14 Other Leading Biologic Products in the Market, 2011Table 6.15 The Wound Care Biologics Development Pipeline, 2011Table 6.16 SWOT Analysis of the Wound Care Biologics Market, 2012-2023Table 7.1 Leading National Markets for Advanced Wound Care ($bn) and Market Shares (%), 2011Table 7.2 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2017Table 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2017-2023Table 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011Table 7.5 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2011-2017Table 7.6 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2017-2023Table 7.7 Chinese Advanced Wound Care Market: Drivers and Restraints, 2012-2023Table 8.1 Leading Companies in the AWC Market: Revenue ($bn) and Market Shares (%), 2011Table 8.2 VAC Therapy at a Glance, 2011Table 8.3 Smith & Nephew Revenue ($bn) and Market Shares (%) by Business Segments, 2011Table 8.4 Smith & Nephew Market Shares (%) by Region, 2011Table 8.5 Smith & Nephew Advanced Wound Management Sales ($bn) by Region, 2011Table 8.6 ConvaTec: Revenue ($m) and Market Share (%) by Business Segments, 2011Table 8.7 ConvaTec Sales ($m) by Region, Revenue ($m) and Market Shares (%) 2011Table 8.8 Coloplast: Revenue ($bn) and Market Share (%) by Segments, 2010/2011Table 8.9 Coloplast Sales ($bn) by Region, 2010/2011Table 8.10 Other Companies in Advanced Wound Care Market, 2011Table 10.1 Global Advanced Wound Care Market: Drivers and Restraints, 2012-2023

List of Figures

Figure 2.1 The Phases of Wound Healing and Duration (Days)

Figure 3.1 Medical Device Market: Global Revenue ($bn) by Sector, 2011

Figure 3.2 Medical Device Market: Market Share(%) by Sector, 2011

Figure 3.3 Global Wound Care Market: Revenue ($bn) by Sector, 2011

Figure 3.4 Global Wound Care Market: Market Shares (%) by Sector, 2011

Figure 3.5 The Advanced Wound Care Market: Revenue ($bn) by Segment, 2011

Figure 3.6 The Advanced Wound Care Market: Market Share (%) by Segment, 2011

Figure 3.7 The Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 4.1 The Moist Wound Care Market: Revenue ($bn) by Segments, 2011

Figure 4.2 The Moist Wound Care Market: Market Share (%) by Segments, 2011

Figure 4.3 Total Moist Wound Care Market Forecast ($bn), 2011-2023

Figure 5.1 The Wound Care Devices: Revenue ($bn) by Segments, 2011

Figure 5.2 The Wound Care Devices: Market Share (%) by Segments, 2011

Figure 5.3 Total Wound Care Devices Market Forecast ($bn), 2011-2023

Figure 5.4 NPWT Wound Therapy Devices Market Forecast ($bn), 2011-2023

Figure 5.5 Ultrasound Wound Therapy Market Forecast ($bn), 2011-2023

Figure 5.6 The NPWT Market Forecast: Revenue ($bn), 2011-2017

Figure 5.7 The NPWT Market Forecast ($bn), 2017-2023

Figure 6.1 The Wound Care Biologics Market: Revenue ($bn) by Segments, 2011

Figure 6.2 The Wound Care Biologics Market: Market Shares (%) by Segments, 2011

Figure 6.3 The Biologics Market Forecast ($bn), 2011-2023

Figure 6.4 The Skin Replacement Market Forecast ($bn), 2011-2017

Figure 6.5 The Skin Replacement Market Forecast ($bn), 2017-2023

Figure 6.6 The Collagen Based Therapy Market Forecast ($bn), 2011-2017

Figure 6.7 The Collagen Based Therapy Market Forecast ($bn), 2017-2023

Figure 6.8 The Cell Therapy Market Forecast ($bn), 2011-2017

Figure 6.9 The Cell Therapy Market Forecast ($bn), 2017-2023

Figure 7.1 The Advanced Wound Care Market: Revenue ($bn) in Leading National Markets, 2011

Figure 7.2 The Advanced Wound Care Market: Market Shares (%) in Leading National Markets, 2011

Figure 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2023

Figure 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011

Figure 7.5 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011

Figure 7.6 The European Advanced Wound Care Market Forecast ($bn) 2011-2023

Figure 7.7 The Advanced Wound Care Market Forecast ($bn) in Germany & France, 2011-2023

Figure 7.8 UK Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.9 Spanish Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.10 Italian Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.11 Japanese Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.12 Chinese Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.13 Indian Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 8.1 Leading Companies in the AWC Market: Revenue ($bn), 2011

Figure 8.2 Leading Companies in the AWC Market: Market Shares (%), 2011

Figure 8.3 Smith & Nephew: Revenue ($bn) by Segments, 2011

Figure 8.4 Smith & Nephew: Market Shares (%) by Segments, 2011

Figure 8.5 Smith & Nephew: Market Shares (%) by Region, 2011

Figure 8.6 Smith & Nephew Advanced Wound Management Sales: Market Share (%) by Region, 2011

Figure 8.7 ConvaTec: Market Share (%) by Business Segment, 2011

Figure 8.8 ConvaTec: Revenue ($m) by Business Segment, 2011

Figure 8.9 ConvaTec Market Shares (%) by Region, 2011

Figure 8.10 Coloplast: Revenue ($bn) by Segments, 2010/2011

Figure 8.11 Coloplast: Market Share (%) by Segments, 2011/2012

Figure 8.12 Coloplast Market Share (%) by Region, 2010/2011

Companies Listed

3MAcellAcryMedActiva Health CareAdvanced Medical SolutionsAgennixAnika TherapeuticsAOTIArgentum MedicalArjoHuntleighArmed Forces Institute of Regenerative Medicine (AFIRM)Arobella MedicalAvita MedicalBiofisicaBiolight ABB.BraunBoehringer IngelheimBrennen MedicalBSN Medical GmbhCardium TherapeuticsCatrixCellerationCentre for Devices and Radiological Health (CDRH)Collagen MatrixColoplastConvaTecCornell UniversityCovalon TechnologiesCovidienCuratecCurasanCytomedixDerma SciencesDeroyalDevon Medical ProductsDiapulse Corporation of AmericaDr. Suwelack Skin & Healthcare Dow-HickamEucare PharmaceuticalsFerrisFibrogenFidia Advanced BiopolymersFood and Drug Administration (FDA) Forticell BioscienceFraunhofer InstituteGarnet BiotherapeuticsGenadyne BiotechnologiesGenzyme BiosurgeryGetingeGreystone PharmaceuticalsHartmann GroupHealthpoint BiotherapeuticsHemCon Medical TechnologiesHollister Wound CareHuman BiosciencesHydroFeraInnovative TherapiesIngenious Technologies CorporationIntegra Life Science CorpInternational Diabetic Federation (IDF)InnocollItalian National Health Service IYIA TechnologiesJohnson & JohnsonKaken PharmaceuticalsKalypto MedicalKinetic ConceptsKuros BiosurgeryLifecellLightwave TechnologiesLescardenLohmann & RauscherMacrocureMarine Polymer Technologies IncMcGowan Institute for Regenerative Medicine Medestea InternazionaleMediWoundMedline IndustriesMiMedXMinistry of Health, Labour and Welfare (MHLW)MisonixMissouri S&T and Mo-Sci CorporationMolnlyckeNara University, JapanNational Competent Authorities (NCA)National Health Service (NHS)NanotherapeuticsNanoVibronixNoble BiomaterialsOculus Innovative SciencesOrganogenesisOsiris TherapeuticsOxygen BiotherapeuticsPhytoceuticalsPolyhealPolynovo BiomaterialsPromethean LifeSciencesProsperaQuick Med TechnologiesRedDressRegeneRx BiopharmaceuticalsRegenesis BiomedicalSafeBlood TechnologiesSangui BioTech InternationalSanuwave HealthShire Regenerative Medicine Smith & NephewSoringSpiracurSynapse MicrocurrentSnyder Wound Research LLCSystagenixTalley GroupTissue GenesisTissue Regeneration TechnologiesUC, BerkleyUDL LaboratoriesULURUUnited Nations (UN)University of CincinnatiUniversity of BathURGOVibrant MedicalVarioVomaris InnovationsWellman Centre for Photomedicine, Harvard University Wound Management TechnologiesWright Medical

To order this report:Medical_Equipment_and_Supply Industry: Advanced Wound Care: World Market Prospects 2013-2023

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Darktrace is the world's leading AI company for cyber security. Created by mathematicians from the University of Cambridge, Darktrace's Enterprise Immune System is the first non-consumer application of machine learning to work at scale, across all network types, from physical, virtualized, and cloud, through to IoT and industrial control systems. Installed as a self-configuring cyber defense platform, Darktrace continuously learns what is ‘normal' for all devices and users, updating its understa...
Most organizations are awash today in data and IT systems, yet they're still struggling mightily to use these invaluable assets to meet the rising demand for new digital solutions and customer experiences that drive innovation and growth. What's lacking are potent and effective ways to rapidly combine together on-premises IT and the numerous commercial clouds that the average organization has in place today into effective new business solutions. New research shows that delivering on multicloud e...
On-premise or off, you have powerful tools available to maximize the value of your infrastructure and you demand more visibility and operational control. Fortunately, data center management tools keep a vigil on memory contestation, power, thermal consumption, server health, and utilization, allowing better control no matter your cloud's shape. In this session, learn how Intel software tools enable real-time monitoring and precise management to lower operational costs and optimize infrastructure...
CloudEXPO has been the M&A capital for Cloud companies for more than a decade with memorable acquisition news stories which came out of CloudEXPO expo floor. DevOpsSUMMIT New York faculty member Greg Bledsoe shared his views on IBM's Red Hat acquisition live from NASDAQ floor. Acquisition news was announced during CloudEXPO New York which took place November 12-13, 2019 in New York City. Our Silicon Valley 2019 schedule will showcase 200 keynotes, sessions, general sessions, power panels, and...
Every organization is facing their own Digital Transformation as they attempt to stay ahead of the competition, or worse, just keep up. Each new opportunity, whether embracing machine learning, IoT, or a cloud migration, seems to bring new development, deployment, and management models. The results are more diverse and federated computing models than any time in our history.
Data center, on-premise, public-cloud, private-cloud, multi-cloud, hybrid-cloud, IoT, AI, edge, SaaS, PaaS... it's an availability, security, performance and integration nightmare even for the best of the best IT experts. Organizations realize the tremendous benefits of everything the digital transformation has to offer. Cloud adoption rates are increasing significantly, and IT budgets are morphing to follow suit. But distributing applications and infrastructure around increases risk, introdu...
Most modern computer languages embed a lot of metadata in their application. We show how this goldmine of data from a runtime environment like production or staging can be used to increase profits. Adi conceptualized the Crosscode platform after spending over 25 years working for large enterprise companies like HP, Cisco, IBM, UHG and personally experiencing the challenges that prevent companies from quickly making changes to their technology, due to the complexity of their enterprise. An accomp...
DevOps has long focused on reinventing the SDLC (e.g. with CI/CD, ARA, pipeline automation etc.), while reinvention of IT Ops has lagged. However, new approaches like Site Reliability Engineering, Observability, Containerization, Operations Analytics, and ML/AI are driving a resurgence of IT Ops. In this session our expert panel will focus on how these new ideas are [putting the Ops back in DevOps orbringing modern IT Ops to DevOps].
Atmosera delivers modern cloud services that maximize the advantages of cloud-based infrastructures. Offering private, hybrid, and public cloud solutions, Atmosera works closely with customers to engineer, deploy, and operate cloud architectures with advanced services that deliver strategic business outcomes. Atmosera's expertise simplifies the process of cloud transformation and our 20+ years of experience managing complex IT environments provides our customers with the confidence and trust tha...
SUSE is a German-based, multinational, open-source software company that develops and sells Linux products to business customers. Founded in 1992, it was the first company to market Linux for the enterprise. Founded in 1992, SUSE is the world's first provider of an Enterprise Linux distribution.
Intel is an American multinational corporation and technology company headquartered in Santa Clara, California, in the Silicon Valley. It is the world's second largest and second highest valued semiconductor chip maker based on revenue after being overtaken by Samsung, and is the inventor of the x86 series of microprocessors, the processors found in most personal computers (PCs). Intel supplies processors for computer system manufacturers such as Apple, Lenovo, HP, and Dell. Intel also manufactu...
Artifex Software began 25-years ago with Ghostscript, a page description language (PDL) interpreter software prevalent in printing and related applications requiring rendering and/or conversion from one software language to another. Founded by renowned computer scientist Dr. L. Peter Deutsch, our company has thrived on the basis of our sharp focus on this area of expertise, a zealous commitment to quality and a strong customer service orientation. Over 100 OEM partners representing some of th...
Moving to Azure is the path to digital transformation, but not every journey is effective. Organizations that start with a cohesive, well-planned migration strategy can avoid common mistakes and stay a step ahead of the competition. Learn from Atmosera CEO, Jon Thomsen about the opportunities and challenges found in three pivotal phases of the journey to the cloud: Evaluation and Architecting, Migration and Management, and Optimization & Innovation. In each phase, there are distinct insights tha...
FinTech is a disruptive innovation that denotes the adoption of technologies that have changed how traditional financial services work. While FinTech is now embedded deeply into the financial services ecosystem, the rise of digital age has paved way to FinTech 2.0 - which is rolling out innovative solutions through emerging technologies at a disruptive pace while maintaining the tenets of security and compliances. Blockchain as a technology has started seeing pilot adoption in FinTech around ...
Now is the time for a truly global DX event, to bring together the leading minds from the technology world in a conversation about Digital Transformation. DX encompasses the continuing technology revolution, and is addressing society's most important issues throughout the entire $78 trillion 21st-century global economy. DXWorldEXPO® has organized these issues along 10 tracks, 22 keynotes and general sessions, and a faculty of 222 of the world's top speakers.